Bringing a novel life sciences or diagnostics instrument to market is a lengthy and costly undertaking, requiring years of planning and execution. Companies understandably focus much of their energy on initial concept development and reducing the associated costs, with less thought into capturing the cost of an instrument over its lifetime. With most devices expected to be operational for 10 years or more, it’s vital to think beyond the initial investment, factoring in the operational costs that impact the financials of both instrument developers and end-users for years to come.
